Syndrome News and Research

RSS

New research: Spinal fluid proteins can differentiate nPTLS from Chronic Fatigue Syndrome

Patients who suffer from Neurologic Post Treatment Lyme disease and those with the Chronic Fatigue Syndrome report similar symptoms. However unique proteins discovered in spinal fluid can distinguish those two groups from one another and also from people in normal health, according to new research conducted by a team led by Steven E. Schutzer, MD, of the University of Medicine and Dentistry of New Jersey - New Jersey Medical School, and Richard D. Smith, Ph.D., of Pacific Northwest National Laboratory.

24 Feb 2011

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

NanoViricides, Inc.announced today that Anil R. Diwan, PhD, President of the Company, gave a presentation on Friday, February 18th, that discussed the Company's anti-viral technology and more specifically, results from both in-vitro and in-vivo studies of its drug candidates against dengue virus infections that can potentially cause a fatal manifestation, viz. dengue hemorrhagic fever.

23 Feb 2011

USC School of Medicine professor to present keynote on prevention of SBS at Texas conference

On February 28th, Harvey Karp, MD, FAAP, Assistant Professor at the USC School of Medicine, will present the keynote address on the prevention of Shaken Baby Syndrome at the 25th Annual Conference of Prevent Child Abuse Texas, in Dallas.

23 Feb 2011

Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA

Most people would never suspect that a "trash tree," one with little economic value and often removed by farmers due to its ability to destroy farmland, could be the key to fighting a deadly bacterium. Now, a University of Missouri researcher has found an antibiotic in the Eastern Red Cedar tree that is effective against methicillin-resistant Staphylococcus aureus, a "superbug" that is resistant to most medications.

22 Feb 2011

NanoString launches fixed-panel assay product for human molecular karyotyping

NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced the first fixed-panel assay product to be developed on its Copy Number Variation detection platform - the nCounter Human Karyotype Panel.

From NanoString Technologies 22 Feb 2011

Noninvasive test to evaluate risk of ASD in infants

A computational physicist and a cognitive neuroscientist at Children's Hospital Boston have come up with the beginnings of a noninvasive test to evaluate an infant's autism risk.

22 Feb 2011

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

Cross-disciplinary teams of scientists studying genetic pathways that are mutated in many forms of cancer, but which also cause certain forms of congenital heart disease - including hypertrophic cardiomyopathy, a thickening of the heart muscle that is the leading cause of sudden death in children and young adults -, have introduced these mutations into mice and successfully treated HCM in the lab.

22 Feb 2011

New study: Rapamycin reverses cardiac muscle damage in LEOPARD syndrome mouse model

Congenital heart diseases affect approximately one in 100 patients, making them the most common type of birth defect and the number-one cause of pediatric deaths.

21 Feb 2011

Lifestyle therapy program may help manage cardiovascular risk factors

Two/thirds of adults with high cholesterol and half with high blood pressure are not being treated effectively for these conditions, according to a recent announcement by the Centers for Disease Control and Prevention (CDC). This disturbing data spotlights the crucial need for new solutions to reduce the risk factors that are behind the current epidemic of chronic illness in the U.S.

21 Feb 2011

Chronic fatigue syndrome – eased by psychotherapy: Study

New British research suggests that people with chronic fatigue syndrome may be helped the most when standard treatment is coupled with cognitive behaviour therapy or exercise therapy.

20 Feb 2011

A special type of Dwarfism protects against cancer & diabetes: Study

Researchers have found that some individuals living in remote villages in Ecuador have a mutation that could throw light on human longevity and ways to increase it. These villagers, all dwarfs with heights less than three and a half feet, have a rare condition called Laron syndrome or Laron dwarfism.

20 Feb 2011

New study to understand dimensions of injuries sustained by soldiers serving overseas

A team of U.S. Army orthopedic surgeons is conducting research to better understand the dimensions of injuries sustained by soldiers serving overseas. The most recent paper in their research series, presented this week at the American Academy of Orthopaedic Surgeons (AAOS) 2011 Annual Meeting, followed a single Brigade Combat Team of 4,122 soldiers over 15 months in Iraq.

19 Feb 2011

BCBSF Foundation honors 5 Florida nonprofits at 2010 Sapphire Award ceremony

Today, five Florida nonprofits were honored for their dedication to improving the health of the state's uninsured and underserved populations at the Sapphire Award ceremony, presented annually by the Blue Cross and Blue Shield of Florida Foundation (BCBSF Foundation).

19 Feb 2011

Medical expert speaks about effects of sugar on human body

With the many forms of sugar available, from table sugar, to high-fructose corn syrup to agave and honey, understanding the differences between sugars and their effects on the body is not all sweet.

18 Feb 2011

New study: Latino siblings of children with disability may face risk of negative outcomes

Latino siblings of children developmental disabilities such as Down syndrome and autism may face their own challenges, including anxiety and lower school performance, according to a new study led by researchers with the Bradley Hasbro Children's Research Center.

17 Feb 2011

Researchers develop new DNA test for accurate detection of Turner syndrome in children

As a child grows, a short stature is not usually cause for concern, but it is often the only sign of a condition called Turner syndrome. Prevalent in girls, Turner syndrome is a genetic defect that short-circuits normal growth and leads to cardiac and renal problems. It is not commonly detected until age 10 or older when a youngster's unusually short height raises suspicions.

16 Feb 2011

The Children's Hospital of Philadelphia establishes Jeffrey Modell Endowed Chair in Pediatric Immunology Research

The Children's Hospital of Philadelphia today announced the establishment of the Jeffrey Modell Endowed Chair in Pediatric Immunology Research.

16 Feb 2011

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Two contracts for advanced development of drugs to treat skin and lung injuries associated with acute radiation syndrome (ARS) were awarded this week by the U.S. Department of Health and Human Services' Biomedical Advanced Research and Development Authority (BARDA). These contracts are the first by BARDA to address the skin and lung injuries that arise from acute exposure to high levels of ionizing radiation - the type of radiation that results from a nuclear blast.

16 Feb 2011

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, gave a presentation about its E. coli O157 cattle vaccine at the First International One Health Congress in Melbourne, Victoria, Australia.

16 Feb 2011

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Aeolus Pharmaceuticals, a biopharmaceutical company developing a new class of broad spectrum catalytic antioxidant compounds that reduce oxidative stress, inflammation, and subsequent tissue damage-signaling cascades resulting from radiation exposure, today announced that the Biomedical Advanced Research and Development Authority, part of the Department of Health and Human Services, has awarded Aeolus a contract for the advanced development of AEOL 10150 as a medical countermeasure against the pulmonary sub-syndrome of acute radiation syndrome.

16 Feb 2011

Syndrome News and Research

New research: Spinal fluid proteins can differentiate nPTLS from Chronic Fatigue Syndrome

Study results of NanoViricides anti-dengue drug candidates presented at NIH/NIAID sponsored conference

USC School of Medicine professor to present keynote on prevention of SBS at Texas conference

Researcher finds antibiotic in Eastern Red Cedar tree effective against MRSA

NanoString launches fixed-panel assay product for human molecular karyotyping

Noninvasive test to evaluate risk of ASD in infants

Mutated cancer pathway studies identify therapeutic targets for congenital heart disease

New study: Rapamycin reverses cardiac muscle damage in LEOPARD syndrome mouse model

Lifestyle therapy program may help manage cardiovascular risk factors

Chronic fatigue syndrome – eased by psychotherapy: Study

A special type of Dwarfism protects against cancer & diabetes: Study

New study to understand dimensions of injuries sustained by soldiers serving overseas

BCBSF Foundation honors 5 Florida nonprofits at 2010 Sapphire Award ceremony

Medical expert speaks about effects of sugar on human body

New study: Latino siblings of children with disability may face risk of negative outcomes

Researchers develop new DNA test for accurate detection of Turner syndrome in children

The Children's Hospital of Philadelphia establishes Jeffrey Modell Endowed Chair in Pediatric Immunology Research

BARDA awards contracts for development of drugs to treat injuries associated with acute radiation syndrome

Bioniche presentation focuses on implementing E. coli cattle vaccine to reduce risk of human infection

Aeolus receives BARDA contract for AEOL 10150 drug development against ARS

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News